Ngm Biopharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
21.25
-0.96
(-4.322%)
Volume:
388,666
52 week range:
14.9 - 32.12
Market Cap:
1.643B
Company Description:
NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.